|
1.
|
|
10 p, 712.3 KB |
Shared decision making in patients with substance use disorders : A one-year follow-up study
/
Serrano-Pérez, Pedro (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Rivero-Santana, Amado (Fundación Canaria Instituto de Investigación Sanitaria de Canarias) ;
Daigre, Constanza (Hospital Universitari Vall d'Hebron) ;
Palma-Álvarez, Raúl Felipe (Hospital Universitari Vall d'Hebron) ;
Nistal-Franco, Icía (Hospital Álvaro Cunqueiro (Vigo)) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Grau-López, Lara (Hospital Universitari Vall d'Hebron)
Patient-centered care in therapeutic processes has been associated with better clinical outcomes, however, it remains a poorly studied aspect in Substance Use Disorder (SUD). The study aimed to evaluate patient's preferences, perceived participation in treatment decisions and activation level; and how they predict retention, pharmacological adherence and substance use during one-year follow-up. [...]
2023 -  10.1016/j.psychres.2023.115540
Psychiatry research, Vol. 329 (2023) , p. 115540
|
|
|
2.
|
|
3 p, 97.3 KB |
Corrigendum : Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females
/
Serra-Navarro, Maria (Hospital Clínic i Provincial de Barcelona) ;
Amoretti, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Verdolini, Norma (Hospital Clínic i Provincial de Barcelona) ;
Forte, Maria Florencia (Hospital Clínic i Provincial de Barcelona) ;
Sánchez-Torres, Ana M. (Instituto de Investigación Sanitaria de Navarra) ;
Vieta, Eduard (Hospital Clínic i Provincial de Barcelona) ;
Clougher, Derek (Hospital Clínic i Provincial de Barcelona) ;
Lobo, Antonio (Instituto de Investigación Sanitaria Aragón) ;
González-Pinto, Ana (Universidad del País Vasco) ;
Panadero, Rocío (Hospital General Universitario Gregorio Marañón) ;
Roldán, Alexandra (Institut d'Investigació Biomèdica Sant Pau) ;
Carvalho, André F. (Deakin University) ;
de la Serna, Elena (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Toll, Alba (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Torrent, Carla (Hospital Clínic i Provincial de Barcelona) ;
Cuesta, Manuel J. (Instituto de Investigación Sanitaria de Navarra) ;
Bernardo, Miquel (Hospital Clínic i Provincial de Barcelona)
Deficits in psychosocial functioning are present in the early stages of psychosis. Several factors, such as premorbid adjustment, neurocognitive performance, and cognitive reserve (CR), potentially influence functionality. [...]
2023 - 10.3389/fpsyt.2023.1200313
Frontiers in psychiatry, Vol. 14 (june 2023)
|
|
|
3.
|
|
14 p, 902.2 KB |
Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases : A systematic review and meta-analysis
/
Li, Lin (Karolinska Institutet (Estocolm, Suècia)) ;
Garcia-Argibay, Miguel (Örebro University) ;
Du Rietz, Ebba (Karolinska Institutet (Estocolm, Suècia)) ;
Brikell, Isabell (Aarhus University) ;
Solmi, Marco (University of Southampton) ;
Cortese, Samuele (University of Nottingham) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ribasés Haro, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Chang, Zheng (Karolinska Institutet (Estocolm, Suècia)) ;
Larsson, Henrik (Karolinska Institutet (Estocolm, Suècia)) ;
Yao, Honghui (Karolinska Institutet (Estocolm, Suècia)) ;
Zhang, Le (Karolinska Institutet (Estocolm, Suècia)) ;
Universitat Autònoma de Barcelona
Attention-deficit/hyperactivity disorder (ADHD) often co-occurs with other psychiatric and physical diseases. However, available evidence on associations between ADHD and cardiovascular diseases (CVDs) is mixed. [...]
2023 - 10.1002/jcv2.12158
JCPP Advances, Vol. 3 (april 2023)
|
|
|
4.
|
|
10 p, 1.9 MB |
Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan
/
Vilar-Ribó, L (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cabana-Domínguez, Judit (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martorell, Lourdes (Universitat Rovira i Virgili) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sanchez-Roige, Sandra (Vanderbilt University Medical Center) ;
Palmer, Abraham A. (Vanderbilt University Medical Center) ;
Vilella, Elisabet (Hospital Universitari Institut Pere Mata) ;
Ribasés Haro, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Muntané, Gerard (Universitat Pompeu Fabra) ;
Soler Artigas, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhealthy lifestyle behaviors, social adversity, and mental health problems that may in turn increase mortality rates. [...]
2023 - 10.1038/s41386-023-01555-x
Neuropsychopharmacology, Vol. 48 (march 2023) , p. 981-990
|
|
|
5.
|
|
|
6.
|
|
9 p, 330.0 KB |
Attention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort
/
Jean, François Arnaud Matthieu (University of Bordeaux) ;
Arsandaux, Julie (University of Bordeaux) ;
Montagni, Ilaria (University of Bordeaux) ;
Collet, Ophélie (University of Bordeaux) ;
Fatséas, Mélina (University of Bordeaux) ;
Auriacombe, Marc (University of Bordeaux) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Côté, Sylvana M. (University of Montreal) ;
Tzourio, Christophe (University of Bordeaux) ;
Galéra, Cédric (University of Bordeaux) ;
Universitat Autònoma de Barcelona
Cannabis use in university students is associated with academic achievement failure and health issues. The objective of the study was to evaluate the association between attention deficit hyperactivity disorder (ADHD) symptoms and cannabis use after 1 year among students according to previous cannabis use. [...]
2022 - 10.1192/j.eurpsy.2022.14
European psychiatry, Vol. 65 (march 2022)
|
|
|
7.
|
|
14 p, 1.3 MB |
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
/
Sforzini, Luca (King's College London) ;
Worrell, Courtney (King's College London) ;
Kose, Melisa (King's College London) ;
Anderson, Ian M. (The University of Manchester and Manchester Academic Health Sciences Centre) ;
Aouizerate, Bruno (University of Bordeaux) ;
Arolt, Volker (University of Münster) ;
Bauer, Michael (University Hospital Carl Gustav Carus) ;
Baune, Bernhard T. (The University of Melbourne) ;
Cleare, Anthony J. (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Cowen, Philip J. (University of Oxford) ;
Dinan, Timothy G. (University College Cork) ;
Fagiolini, Andrea (University of Siena) ;
Ferrier, I. Nicol (Newcastle University) ;
Hegerl, Ulrich (Goethe University) ;
Krystal, Andrew D. (Duke University School of Medicine) ;
Leboyer, Marion (Université Paris Est Creteil (UPEC)) ;
McAllister-Williams, R. Hamish (Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust) ;
McIntyre, Roger S. (Brain and Cognition Discovery Foundation) ;
Meyer-Lindenberg, Andreas (Heidelberg University) ;
Miller, Andrew H. (Emory University School of Medicine) ;
Nemeroff, Charles B. (University of Texas at Austin) ;
Normann, Claus (Medical Center - University of Freiburg) ;
Nutt, David (Imperial College) ;
Pallanti, Stefano (University of Florence) ;
Pani, Luca (VeraSci) ;
Penninx, Brenda W. J. H. (Vrije Universiteit and GGZinGeest) ;
Schatzberg, Alan F. (Stanford University) ;
Shelton, Richard C. (University of Alabama at Birmingham) ;
Yatham, Lakshmi N. (University of British Columbia) ;
Young, Allan H. (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Zahn, Roland (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Aislaitner, Georgios (Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM)) ;
Butlen-Ducuing, Florence (European Medicines Agency) ;
Fletcher, Christine (Biostatistics, GlaxoSmithKline) ;
Haberkamp, Marion (Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM)) ;
Laughren, Thomas (Laughren Psychopharm Consulting) ;
Mäntylä, Fanni-Laura (GAMIAN-Europe (Global Alliance of Mental Illness Advocacy Networks-Europe)) ;
Schruers, Koen (University of Leuven) ;
Thomson, Andrew (European Medicines Agency) ;
Arteaga-Henríquez, Gara (Hospital Universitari Vall d'Hebron) ;
Benedetti, Francesco (IRCCS Scientific Institute Ospedale San Raffaele) ;
Cash-Gibson, Lucinda (Hospital Universitari Vall d'Hebron) ;
Chae, Woo Ri (Charité - Universitätsmedizin Berlin) ;
De Smedt, Heidi (Janssen Research & Development) ;
Gold, Stefan M. (University Medical Center Hamburg-Eppendorf) ;
Hoogendijk, Witte J. G. (Erasmus University Medical Centre) ;
Mondragón, Valeria Jordán (Medical Director Neuroscience for Region Europe at Novartis Pharma) ;
Maron, Eduard (West Tallinn Central Hospital) ;
Martynowicz, Jadwiga (Janssen Research & Development) ;
Melloni, Elisa (IRCCS Scientific Institute Ospedale San Raffaele) ;
Otte, Christian (Charité - Universitätsmedizin Berlin) ;
Perez-Fuentes, Gabriela (Hospital Universitari Vall d'Hebron) ;
Poletti, Sara (IRCCS Scientific Institute Ospedale San Raffaele) ;
Schmidt, Mark E. (Janssen Pharmaceutica NV) ;
van de Ketterij, Edwin (European Infrastructure for Translational Medicine (EATRIS)) ;
Woo, Katherine (Janssen Research & Development) ;
Flossbach, Yanina (Novartis Pharma AG) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Savitz, Adam J. (Department of Neuroscience) ;
Pariante, Carmine M (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Universitat Autònoma de Barcelona
Criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD) as subtypes of major depressive disorder (MDD) are not unequivocally defined. In the present document we used a Delphi-method-based consensus approach to define TRD and PRD and to serve as operational criteria for future clinical studies, especially if conducted for regulatory purposes. [...]
2021 - 10.1038/s41380-021-01381-x
Molecular psychiatry, Vol. 27 (december 2021) , p. 1286-1299
|
|
|
8.
|
|
15 p, 471.4 KB |
Prodromal phase : Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood
/
Verdolini, Norma (Hospital Clínic i Provincial de Barcelona) ;
Borràs, Roger (Hospital Clínic i Provincial de Barcelona) ;
Sparacino, Giulio (Hospital Clínic i Provincial de Barcelona) ;
Garriga, Marina (Hospital Clínic i Provincial de Barcelona) ;
Sagué-Vilavella, Maria (Hospital Clínic i Provincial de Barcelona) ;
Madero, Santiago (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Palacios-Garrán, Roberto (Hospital Clínic i Provincial de Barcelona) ;
Serra, Maria (Hospital Clínic i Provincial de Barcelona) ;
Forte, Maria Florencia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Salagre, Estela (Hospital Clínic i Provincial de Barcelona) ;
Aedo, Alberto (Hospital Clínic i Provincial de Barcelona) ;
Salgado-Pineda, Pilar (FIDMAG Germanes Hospitalàries Research Foundation) ;
Salvatierra, Irene Montoro (Universitat Rovira i Virgili) ;
Sánchez Gistau, Vanessa (Universitat Rovira i Virgili) ;
Pomarol-Clotet, Edith (FIDMAG Germanes Hospitalàries Research Foundation) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Carvalho, Andre F. (Deakin University) ;
Garcia Rizo, Clemente (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Undurraga, Juan (Instituto Psiquiátrico Dr. J. Horwitz Barak) ;
Reinares, María (Hospital Clínic i Provincial de Barcelona) ;
Martínez-Àran, Anabel (Hospital Clínic i Provincial de Barcelona) ;
Bernardo, Miquel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Vieta, Eduard (Hospital Clínic i Provincial de Barcelona) ;
Pacchiarotti, Isabella (Hospital Clínic i Provincial de Barcelona) ;
Amoretti, Silvia (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
This study was aimed at identifying differences in the prodromal symptoms and their duration, risk factors and markers of vulnerability in patients presenting a first episode mania (FEM) or psychosis (FEP) with onset in late adolescence or adulthood in order to guide tailored treatment strategies. [...]
2022 - 10.1111/acps.13415
Acta psychiatrica Scandinavica, Vol. 146 (february 2022) , p. 36-50
|
|
|
9.
|
|
8 p, 704.8 KB |
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder : protocol and clinical characteristics of the INCAS study
/
Brynte, Christoffer (Karolinska Institutet (Estocolm, Suècia)) ;
Aeschlimann, Myriam (University of Bern) ;
Barta, Csaba (Semmelweis University) ;
Begeman, Alex Hendikus Abraham (De Hoop Ggz) ;
Bäcker, Amanda (Karolinska Institutet (Estocolm, Suècia)) ;
Crunelle, Cleo Lina (Vrije Universiteit Brussel) ;
Daigre, Constanza (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
De Fuentes-Merillas, Laura (Novadic-Kentron Addiction Care) ;
Demetrovics, Zsolt (University of Gibraltar) ;
Dom, Geert (PC Multiversum) ;
Grau-López, Lara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Icick, Romain (Université de Paris Cité) ;
Johnson, Brian (SUNY Upstate University) ;
Joostens, Peter (Alexianen Zorggroep Tienen) ;
Kapitány-Fövény, Máté (National Institute of Mental Health) ;
Karsinti, Emily (Université Paris-Nanterre) ;
Kiefer, Falk (Mannheim Center for Translational Neurosciences) ;
Konstenius, Maija (Karolinska Institutet (Estocolm, Suècia)) ;
Levin, Frances R. (New York State Psychiatric Institute) ;
Luderer, Mathias (University Hospital of Frankfurt (Alemanya)) ;
Markus, Wiebren (Iriszorg Addiction Care) ;
Matthys, Frieda (Vrije Universiteit Brussel) ;
Moggi, Franz (University Hospital of Psychiatry) ;
Palma-Álvarez, Raúl Felipe (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Paraskevopoulou, Maria (RadboudumcDonders Institute for Brain) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Schellekens, Arnt (Nijmegen Institute for Scientist Practitioners in Addiction) ;
Soravia, Leila M. (Südhang Clinic) ;
Therribout, Norman (Université Paris-Nanterre) ;
Thomas, Anil (NYU Grossman School of Medicine) ;
van de Glind, Geurt (University of Applied Sciences-Utrecht) ;
van Kernebeek, Michiel Willem (Vrije Universiteit Brussel) ;
Vollstädt-Klein, Sabine (University of Heidelberg) ;
Vorspan, Florence (Université de Paris Cité) ;
van den Brink, Wim (Amsterdam UMC. University Medical Center) ;
Franck, Johan (Karolinska Institutet (Estocolm, Suècia)) ;
Universitat Autònoma de Barcelona
Substance use disorders (SUD) often co-occur with attention deficit hyperactivity disorder (ADHD). Although the short-term effects of some specific interventions have been investigated in randomized clinical trials, little is known about the long-term clinical course of treatment-seeking SUD patients with comorbid ADHD. [...]
2022 - 10.1186/s12888-022-04259-6
BMC Psychiatry, Vol. 22 (september 2022)
|
|
|
10.
|
|
9 p, 280.6 KB |
Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder : A Prospective Study on the Effects of Time
/
Ferrer Vinardel, Marc (Hospital Universitari Vall d'Hebron) ;
Soto-Angona, Óscar (Hospital Universitari Vall d'Hebron) ;
Soler Artigas, María (Hospital Universitari Vall d'Hebron) ;
Ibáñez, Pol (Hospital Universitari Vall d'Hebron) ;
Fadeuilhe, Christian (Hospital Universitari Vall d'Hebron) ;
Palma-Álvarez, Raúl Felipe (Hospital Universitari Vall d'Hebron) ;
Lidai, Raquefet (Hospital Universitari Vall d'Hebron) ;
Vargas-Cáceres, Sebastian (Hospital Universitari Vall d'Hebron) ;
Torrecilla, María Ángeles (Hospital Universitari Vall d'Hebron) ;
López Illamola, Anna (Hospital Universitari Vall d'Hebron) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Agitation in patients diagnosed with personality disorders (PD) is one of the most frequent crises in emergency departments (ED). Although many medications have been tested, their effectiveness has been small or non-significant, and no specific drugs are supported by the available evidence. [...]
2022 - 10.9758/cpn.2022.20.3.482
Clinical Psychopharmacology and Neuroscience, Vol. 20 (august 2022) , p. 482-490
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
